04:40 PM EDT, 03/19/2026 (MT Newswires) -- Damora Therapeutics ( DMRA ) reported FY 2025 earnings late Thursday of $3.98 per diluted share, swinging from a loss of $18.53 a year earlier.
Three analysts polled by FactSet expected a loss of $0.96.
Cash and cash equivalents were approximately $257.6 million as of Dec. 31.
Shares were down more than 2.6% in after-hours trading.